MapLight Therapeutics (MPLT) Amortizatization of Intangibles (2024 - 2025)

MapLight Therapeutics' (MPLT) quarterly Amortizatization of Intangibles came in at $1.4 million in Q4 2025, up 252.57% year-on-year from $409000.0 in Q4 2024, and up 252.57% quarter-over-quarter from $409000.0 in Q4 2024.

MapLight Therapeutics (MPLT) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

MapLight Therapeutics has disclosed Amortizatization of Intangibles across 2 years of filings, most recently posting $1.4 million for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 13,267.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 MapLight Therapeutics 248.88 Mn 248.88 Mn - 1.44 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.44 Mn
Dec 31, 2025 1.44 Mn
Dec 31, 2024 409,000.00
Dec 31, 2024 409,000.00